chronic plaque psoriasis epidemiology forecast

Chronic Plaque Psoriasis Insights and Trends

• Chronic Plaque Psoriasis is a common immune-mediated inflammatory skin disorder with a global prevalence estimated at approximately 2–3% of the population, making it one of the most prevalent chronic dermatological conditions worldwide. The disease burden is increasing in several regions due to rising obesity, metabolic syndrome, smoking, stress, and aging populations.

• In the United States and Europe, psoriasis affects ~2–4% of adults, based on large epidemiological studies and national registry data, contributing significantly to dermatology outpatient visits, long-term treatment use, and healthcare expenditure.

• Psoriasis shows a bimodal age distribution, with peak onset commonly occurring between 15 and 35 years and a second smaller peak in older adults. The disease affects both sexes relatively equally, although some studies report a slight male predominance in moderate-to-severe disease.

Chronic Plaque Psoriasis Epidemiology Forecast in the 7MM

• 2025 Diagnosed Prevalent Cases of Chronic Plaque Psoriasis: ~XX

• 2036 Projected Diagnosed Prevalent Cases of Chronic Plaque Psoriasis: ~XXX

• Chronic Plaque Psoriasis  Growth Rate (2026–2036): ~XX% CAGR

DelveInsight's ‘Chronic Plaque Psoriasis Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Chronic Plaque Psoriasis, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Chronic Plaque Psoriasis Understanding 

Chronic Plaque Psoriasis Overview and Diagnosis

Psoriasis is a chronic immune-mediated inflammatory skin disorder characterized by erythematous, well-demarcated plaques with silvery scales, most commonly presenting as plaque psoriasis. The disease is associated with immune dysregulation involving TNF-α, IL-17, and IL-23 pathways and is frequently linked with comorbidities such as psoriatic arthritis, obesity, diabetes, cardiovascular disease, and depression.

Further details are provided in the report.

Chronic Plaque Psoriasis Diagnosis

Diagnosis of psoriasis is primarily based on clinical evaluation and characteristic findings such as well-demarcated erythematous plaques with silvery scales. In uncertain cases, skin biopsy and histopathological examination may be performed to confirm the diagnosis and differentiate psoriasis from other inflammatory skin disorders. Additional assessments, including evaluation of disease severity, body surface area involvement, nail changes, and psoriatic arthritis symptoms, help guide treatment selection and long-term disease management.

Further details are provided in the report.

Chronic Plaque Psoriasis Epidemiology

Key Findings from Chronic Plaque Psoriasis Epidemiological Analysis and Forecast 

• As per the Centers for Disease Control and Prevention, Psoriasis is the most common inflammatory disease in the United States, affecting approximately as many as 7.4 million American adults.

• According to estimates, about 80 to 90% of people living with psoriasis experience plaque psoriasis.

• Psoriasis is prevalent worldwide, with a global prevalence of 1% to 8%. It begins in childhood in approximately one-third of cases.

• As per the National Psoriasis Foundation, the most common form of psoriasis, plaque psoriasis, appears as raised, red patches covered with a silvery white buildup of dead skin cells.  Approximately 20% of people with psoriasis have moderate-to-severe plaque psoriasis.

• The most common form of Psoriasis is Chronic Plaque Psoriasis, affecting about 90% of psoriasis patients, with about 20%–30% of them suffering from a moderate or severe condition.

• It is estimated that males are slightly more affected by chronic plaque psoriasis than females.

Scope of the Report

• The report covers a segment of a descriptive overview of chronic plaque psoriasis, explaining its causes, signs and symptoms, and pathogenesis.

• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression. 

Report Insights

Chronic Plaque Psoriasis Patient Population Forecast

Report Key Strengths

• Epidemiology‑based (Epi‑based) Bottom‑up Forecasting

• 11-year Forecast 

• Patient Burden Trends (by geography)

Key Question

• What are the disease risks, burdens, and unmet needs of chronic plaque psoriasis? What will be the growth opportunities across the 7MM concerning the patient population with chronic plaque psoriasis?

• What is the historical and forecasted chronic plaque psoriasis patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.

• To understand key opinion leaders’ perspectives on the diagnostic challenges to overcome barriers in the future.

• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.